SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-197413
Filing Date
2014-05-14
Accepted
2014-05-13 18:40:54
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d704630d10q.htm 10-Q 481950
2 EX-10.3 d704630dex103.htm EX-10.3 9838
3 EX-31.1 d704630dex311.htm EX-31.1 6066
4 EX-31.2 d704630dex312.htm EX-31.2 6077
5 EX-32.1 d704630dex321.htm EX-32.1 3502
  Complete submission text file 0001193125-14-197413.txt   2809744

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT epzm-20140331.xml EX-101.INS 283387
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20140331.xsd EX-101.SCH 31914
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20140331_cal.xml EX-101.CAL 39693
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20140331_def.xml EX-101.DEF 61573
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20140331_lab.xml EX-101.LAB 257083
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20140331_pre.xml EX-101.PRE 165778
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 14838772
SIC: 2834 Pharmaceutical Preparations